3. Arbutus sued to avoid patent dispute over Pfizer/BioNTech COVID-19 shot
습관중독
Mar. 18, 2022 Acuitas Therapeutics, a Canadian private biotechnology company whose technology has been used in Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) COVID-19 shot, filed a lawsuit in the U.S. against Arbutus Biopharma (NASDAQ:ABUS +1.3%) seeking to head off claims that the vaccine violates Arbutus’ patents. According to Reuters, Vancouver-based Acuitas had asked the Manhattan federal court to..